CN Stock MarketDetailed Quotes

301333 R&G PharmaStudies

Watchlist
  • 52.70
  • +3.36+6.81%
Market Closed Feb 14 15:00 CST
5.09BMarket Cap42.03P/E (TTM)

R&G PharmaStudies Key Stats

R&G PharmaStudies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 966.000M--
--2024/FY-- / 789.500M--
--2023/FY721.373M / 770.000M--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 966.000M--
--2024/FY-- / 789.500M--
--2023/FY721.373M / 770.000M--
--------
--------

Unlock Free Earnings Estimates

R&G PharmaStudies Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Feb 16, 2025

Strong Buy

  • Strong Buy

    63.64%
  • Buy

    36.36%
  • Hold

    0.00%
  • Underperform

    0.00%
  • Sell

    0.00%

Price Target

No Data